Results 131 to 140 of about 37,273 (171)

SUBRETINAL PIGMENT EPITHELIUM OPTICALLY EMPTY STRUCTURES IN POLYPOIDAL CHOROIDAL VASCULOPATHY: A Novel Optical Coherence Tomography Finding. [PDF]

Retina
Teo KYC, Chong YJ, Cheung CMG.
europepmc   +1 more source

Two-year outcomes of intravitreal conbercept therapy for polypoidal choroidal vasculopathy. [PDF]

BMC Ophthalmol
Liu Y, Guo J, Tang W, Xu G, Liu W.
europepmc   +1 more source

Comparative Efficacy of Brolucizumab and Aflibercept in Polypoidal Choroidal Vasculopathy: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Allehyani MH, Alsaeedi AK, Alqthmi RO, Saleh RE, Alsamli RS, Almalki HA, Alshehri AF, Felimban SA, Kambiji GJ, Almatrafi MI, Othman B.   +10 more
europepmc   +1 more source

Preferential Locations of Polypoidal Lesions and Adjacent Pigment Epithelium Detachments in Polypoidal Choroidal Vasculopathy in a Japanese Population. [PDF]

Invest Ophthalmol Vis Sci
Kogo T, Muraoka Y, Hata M, Ishikura M, Nishigori N, Akiyama Y, Ueda-Arakawa N, Miyata M, Ooto S, Takahashi A, Miyake M, Tsujikawa A.   +11 more
europepmc   +1 more source

Usage of brolucizumab as treatment for wet age-related macular degeneration (AMD) and polypoidal choroidal vasculopathy (PCV): A narrative review. [PDF]

Medicine (Baltimore)
Jezani SN, Bastion MC.
europepmc   +1 more source

Aflibercept With vs Without Reduced-Fluence Photodynamic Therapy for Polypoidal Choroidal Vasculopathy: A Randomized Clinical Trial.

JAMA Ophthalmol
Chong YJ, Teo KYC, Wong W, Tan ACS, Su X, Gilead N, Chan HH, Ibrahim F, Fenner B, Ong C, Sun C, Sim S, Chee C, Chakravarthy U, Cheung CMG.   +14 more
europepmc   +1 more source

Comparative outcomes of pars plana vitrectomy with subretinal rt-PA injection in polypoidal choroidal vasculopathy: the role of simultaneous anti-VEGF treatment. [PDF]

Front Med (Lausanne)
Chen L, Wang C, Zhang W, Meng L, Sun L, Chen Y.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Polypoidal choroidal vasculopathy

Survey of Ophthalmology, 2004
Polypoidal choroidal vasculopathy was first described as a peculiar hemorrhagic disorder of the macula, characterized by recurrent sub-retinal and sub-retinal pigment epithelium bleeding in middle aged black women. The use of indocyanine green angiography and subsequently of optical coherent tomography has widened our ability to study and understand ...
Lawrence A Yannuzzi, Antonio P Ciardella
exaly   +6 more sources

Polypoidal Choroidal Vasculopathy in Asians

Journal of Clinical Medicine, 2015
Age related macular degeneration (AMD) in Asians has been suggested to differ from their Western counterparts in terms of epidemiology, pathogenesis, clinical presentation and treatment. In particular, polypoidal choroidal vasculopathy (PCV) appears to be the predominant subtype of exudative AMD in Asian populations, in contrast to choroidal ...
Wong Chee Wai, Chui Ming Gemmy Cheung
exaly   +4 more sources

Polypoidal choroidal vasculopathy

Ophthalmology Clinics of North America, 2002
Polypoidal choroidal vasculopathy seems to be a distinct clinical entity that should be differentiated from other types of CNV associated with AMD and other known choroidal degenerative, inflammatory, and ischemic disorders. The principle abnormality seen in PCV, notably the branching vascular network and polypoidal structures at the borders of the ...
Antonio P, Ciardella, Irene M, Donsoff, Lawrence A, Yannuzzi   +2 more
openaire   +2 more sources